Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2005
05/25/2005EP1531857A1 Metalloproteinase inhibitors
05/25/2005EP1531851A2 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
05/25/2005EP1531850A2 Use of il-21 in cancer and other therapeutic applications
05/25/2005EP1531848A2 Gene differentially expressed in breast and bladder cancer and encoded polypeptides
05/25/2005EP1531846A2 Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use
05/25/2005EP1531842A2 Regulation of cell growth by muc1
05/25/2005EP1531836A2 Polypeptide cleavage process
05/25/2005EP1531825A2 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases
05/25/2005EP1531791A2 Prevention and reduction of blood loss
05/25/2005EP1531692A1 Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants
05/25/2005EP1531676A2 Compositions and methods for liver growth and liver protection
05/25/2005EP1531664A2 Genes encoding proteins with pesticidal activity
05/25/2005EP1406483A4 Genes for modifying plant traits iv
05/25/2005EP1287137B1 REGULATION OF HUMAN $g(a)1A?ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
05/25/2005EP1187914B1 A structured peptide scaffold for displaying turn libraries on phage
05/25/2005EP1163335B1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
05/25/2005EP1162992B1 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use
05/25/2005EP1068530B1 Diagnostic for metastatic prostate cancer
05/25/2005EP1023320B1 PEPTIDES DERIVED FROM THE env GENE OF THE FELINE IMMUNODEFICIENCY VIRUS AND THEIR APPLICATIONS
05/25/2005EP0994903B1 Methods and compositions for galactosylated glycoproteins
05/25/2005EP0981637B1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
05/25/2005EP0966206B1 Frozen food product containing antifreeze peptides
05/25/2005EP0907370B1 Hla-a2.1 binding peptides and their uses
05/25/2005EP0888541B1 Cryptic peptides and method for their identification
05/25/2005EP0871702B1 Cytokine designated lerk-7
05/25/2005EP0813419B1 Modulators of regulatory proteins
05/25/2005EP0755451B1 Materials and methods for management of hyperacute rejection in human xenotransplantation
05/25/2005EP0688227B1 Production of human papillomavirus capsid protein and virus-like particles
05/25/2005EP0479866B2 Pestivirus nucleotide sequences and polypeptides, in particular from hog cholera virus
05/25/2005DE202004019129U1 Genetically-modified rodent for use in established experimental systems, exhibits homozygote knock-out of interferon receptor alpha-chain
05/25/2005CN1620655A System and method for controlling user interface attribute by data
05/25/2005CN1620510A Cytokine protein family
05/25/2005CN1620507A Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium
05/25/2005CN1620500A Corona-virus-like particles comprising functionally deleted genomes
05/25/2005CN1620498A Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability
05/25/2005CN1620467A Secreted protein
05/25/2005CN1620466A Cystine-knot fold protein
05/25/2005CN1620465A Process for preparing recombined placental growth factor
05/25/2005CN1620464A Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumors
05/25/2005CN1620430A 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of PPAR-alpha
05/25/2005CN1620313A Method of examining effect of angiogenesis inhibitors mediated by the inhibition of integrin expression
05/25/2005CN1620310A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
05/25/2005CN1620308A Use of a pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention
05/25/2005CN1620306A Systems and methods for treating patients with collagen-rich material extracted from adipose tissue
05/25/2005CN1619312A Specific markers for metabolic syndrome
05/25/2005CN1618977A Method of revealing target protein on cell surface using bactospein S layer protein as carrier and application thereof
05/25/2005CN1618973A Fusion polynucleotide fusion polypeptide pessessing salt resistance character and expression carrier
05/25/2005CN1618970A Method for producing L-amino acid using methylotroph
05/25/2005CN1618969A Mammalian sytokine-like polypeptide-10
05/25/2005CN1618967A Configuration of high effect expression serum albumin yeast strain and fermentation purification technology
05/25/2005CN1618965A New type Japanese blood fluxes dominant pesition antigen molecule
05/25/2005CN1618811A Cell surface molecule mediating cell adhesion and signal transmission
05/25/2005CN1618810A New mastocancer related protein and its specificity multiclone antibody
05/25/2005CN1618809A New mastocancer related protein and its specificity multiclone antibody
05/25/2005CN1618808A Liver cancer related protein and its coding sedquence and use
05/25/2005CN1618807A 分泌蛋白及其编码序列和用途 Secreted proteins and their coding sequences and uses
05/25/2005CN1618806A Liver cancer inhibition factor and its coding sequence and use
05/25/2005CN1618805A Nerve system development related protein and its coding sequence and use
05/25/2005CN1618804A Paddy rice potassium, sodium ion transport gene and its application
05/25/2005CN1618803A Recombinated phycobiliprotein and its preparation method and application
05/25/2005CN1618802A Tetramer combined with SARS antigen peptide and its preparation and use
05/25/2005CN1203183C Retroviral vectors comprising functional splice donor site and a functional splice acceptor site
05/25/2005CN1203180C BASB006 polynucleotide(s) and polypeptide from neisseria meningitis
05/25/2005CN1203179C DNA sequence and recombination production method of graminae allergen
05/25/2005CN1203177C Tumor antigen proteins, genes thereof and tumor antigen peptides
05/25/2005CN1203171C Bacillus protein production cell
05/25/2005CN1203093C Method for producing whole silkworm powder milk-containing and ferritin
05/25/2005CN1203092C Process for preparing transgenic coat producing milk containing human granulocyte-colony stimulating factor
05/25/2005CN1203091C TGF (b) 1 inhibitor peptides
05/25/2005CN1203088C Peptide with affinity for clotting factor VIII
05/25/2005CN1203086C Protein composition and process for isolating protein composition from muscle source
05/25/2005CN1202864C Use of CD40:CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
05/25/2005CN1202862C Compsns. comprising comjugates of stable, active, human OB protein with antibody Fc chain and methods
05/25/2005CN1202860C Anti-SARS virus transfer factor preparation method
05/24/2005US6897359 Carnation antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants
05/24/2005US6897356 Thioredoxin H homologs
05/24/2005US6897301 Use in diagnostic methods and as immunogens
05/24/2005US6897297 Hydrophobically-modified protein compositions and methods
05/24/2005US6897295 For diagnosis/drug screening in vivo apoptosis controllers; genetic engineering
05/24/2005US6897294 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
05/24/2005US6897293 A DNA sequence encoding a gax protein or portion, which inhibits vascular smooth muscle cell proliferation, useful in the treatment of blood vessel diseases
05/24/2005US6897292 For detecting a genetic abnormality, cancer
05/24/2005US6897291 For drug screening agonists/antagonists; for germ cell development/fertilization; amphibian oocyte expression
05/24/2005US6897290 Regulators of complement activation (RCA); diagnosis/therapy of complement system for autoimmune disease treatment; open reading frames; point mutations; membrane cofactor/decay accelerating factor/factor H
05/24/2005US6897288 Mage-A12 antigenic peptides and uses thereof
05/24/2005US6897287 Ro/SSA peptide reagents for diagnosis of autoantibodies
05/24/2005US6897286 Polypeptide for use in the treatment of gastrointestinal disorders
05/24/2005US6897197 Method of inhibiting cell proliferation using an anti-oncogene protein
05/24/2005US6897063 Accessory functions for use in recombinant AAV virion production
05/24/2005US6897062 For diagnosis/therapy of cancer/tumors in vitro; refractories
05/24/2005US6897057 Cell-specific and/or tumor-specific promoter retargeting of herpes γ 34.5 gene expression
05/24/2005US6897054 For controlling in vitro cell proliferation; genetic engineering
05/24/2005US6897045 Adeno-associated virus vectors
05/24/2005US6897043 Nucleotide sequences for use as efficient gene transfer and cloning tool in genetic engineering
05/24/2005US6897042 Low-temperature inducible expression vector
05/24/2005US6897041 For treating/preventing staphylococcal infections; transcription regulators; ion exchange resins; bacteriophages; genetic engineering/cloning
05/24/2005US6897039 For treatment of cardiovascular diseases.
05/24/2005US6897030 CDNA sequence encoding porcine brain natriuretic peptide and related genes encoding canine and human peptides with natriuretic activity are disclosed. The gene is shown to make accessible the DNAs encoding analogous natriuretic peptides in
05/24/2005US6897029 For drug screening anticancer agents; genetic engineering; differential isoform splicing
05/24/2005US6897024 Nucleic acid molecules comprising the promoter for PCA3, and uses thereof